Daniel Hesselson

Dr. Daniel Hesselson is an Adjunct Associate Professor at the University of Sydney within the Faculty of Medicine and Health, affiliated with the Centenary Institute Cancer Medicine and Cell Biology. His research focuses on molecular mechanisms in zebrafish models, including CRISPR genome editing, cardiac development, and environmental toxicology. He has contributed to studies on vitamin D metabolism, SARS-CoV-2 biology, and PFAS exposure impacts.

Education: Not explicitly stated in available texts.

Research Interests:

• Zebrafish genetics and behavior modeling
• Autophagy and cellular stress responses
• Cardiac regeneration and developmental pathways
• Environmental toxin exposure effects
• CRISPR-based genome editing technologies

Grants & Funding:

• 2024: Cancer Australia Grant for chemoresistant ovarian cancer research (collaborating with Prof. Cole)
• 2023: NHMRC Ideas Grant for directed evolution of KLF1 in cardiac repair
• 2022: Lambert Initiative grant for high-throughput drug discovery

Labs/Teams: Collaborates extensively with the Neely Lab (cell signaling) and Cole Lab (cardiovascular research) at the Centenary Institute.